Cargando…

Parathyroid hormone change after cinacalcet initiation and one-year clinical outcome risk: a retrospective cohort study

BACKGROUND: Cinacalcet reduces parathyroid hormone (PTH) levels in patients receiving hemodialysis, but no non-experimental studies have evaluated the association between changes in PTH levels following cinacalcet initiation and clinical outcomes. We assessed whether short-term change in PTH levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	St. Peter, Wendy L, Yusuf, Akeem A, Do, Thy, Lowe, Kimberly A, Liu, Jiannong, Nieman, Kimberly M, Bradbury, Brian D, Collins, Allan J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4383071/ https://www.ncbi.nlm.nih.gov/pubmed/25886282 http://dx.doi.org/10.1186/s12882-015-0030-8

Ejemplares similares

Intact parathyroid hormone and whole parathyroid hormone assay results disagree in hemodialysis patients under cinacalcet hydrochloride therapy
por: Koda, Ryo, et al.
Publicado: (2014)

Rescue of High Glucose Impairment of Cultured Human Osteoblasts Using Cinacalcet and Parathyroid Hormone
por: Shahen, V. A., et al.
Publicado: (2023)

SAT-349 Cinacalcet Resistant Tertiary Hyperparathyroidism with One Large Parathyroid Gland
por: Chaker, Bayan, et al.
Publicado: (2020)

Parathyroid Apoplexy Following Cinacalcet Treatment in Primary Hyperparathyroidism
por: Di Dalmazi, Giulia, et al.
Publicado: (2018)

Cinacalcet for Hypercalcemia Caused by Pulmonary Squamous Cell Carcinoma Producing Parathyroid Hormone-Related Peptide
por: Bech, Anneke, et al.
Publicado: (2012)

Dynamics of cinacalcet use and biochemical control in hemodialysis patients: a retrospective New-user cohort design
por: Reams, B. Diane, et al.
Publicado: (2015)

Rapid Decrease of Intact Parathyroid Hormone Could Be a Predictor of Better Response to Cinacalcet in Hemodialysis Patients
por: Kim, Jwa-Kyung, et al.
Publicado: (2013)

The use of cinacalcet in pregnancy to treat a complex case of parathyroid carcinoma
por: Nadarasa, K, et al.
Publicado: (2014)

The Effect of the Frequently Used Cinacalcet for pHPT during the COVID-19 Pandemic on Perioperative Decrease in Parathyroid Hormone
por: Radulova-Mauersberger, Olga, et al.
Publicado: (2022)

Successful use of cinacalcet to treat parathyroid-related hypercalcemia in two pediatric patients
por: Mogas, E, et al.
Publicado: (2018)

Serum phosphorus reduction in dialysis patients treated with cinacalcet for secondary hyperparathyroidism results mainly from parathyroid hormone reduction
por: Zitt, Emanuel, et al.
Publicado: (2013)

The administration of cinacalcet hydrochloride just before a haemodialysis session suppresses the transient rise in intact parathyroid hormone induced by a low-calcium dialysate: when should cinacalcet hydrochloride be administered?
por: Date, Toshiyuki, et al.
Publicado: (2008)

Case report of a cystic parathyroidal adenoma with rapid growth induced by cinacalcet
por: Werner, Christoph, et al.
Publicado: (2020)

Mechanistic analysis for time-dependent effects of cinacalcet on serum calcium, phosphorus, and parathyroid hormone levels in 5/6 nephrectomized rats
por: Wu-Wong, J Ruth, et al.
Publicado: (2013)

Cholecalciferol Additively Reduces Serum Parathyroid Hormone Levels in Severe Secondary Hyperparathyroidism Treated with Calcitriol and Cinacalcet among Hemodialysis Patients
por: Zheng, Cai-Mei, et al.
Publicado: (2018)

Association Between Resistance to Cinacalcet and Parathyroid Gland Hyperplasia in Kidney Transplant Recipients with Persistent Hypercalcemia
por: Oruc, A., et al.
Publicado: (2020)

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis
por: Block, Geoffrey A., et al.
Publicado: (2016)

Successful cinacalcet treatment of refractory secondary hyperparathyroidism due to multiple lung parathyroid adenomas
por: Sugi, Orie, et al.
Publicado: (2010)

Factors associated with parathyroid hormone control in haemodialysis patients with secondary hyperparathyroidism treated with cinacalcet in real-world clinical practice: Mimosa study
por: Rottembourg, Jacques, et al.
Publicado: (2019)

Cinacalcet HCl prevents development of parathyroid gland hyperplasia and reverses established parathyroid gland hyperplasia in a rodent model of CKD
por: Miller, Gerald, et al.
Publicado: (2012)

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients
por: Danese, Mark D., et al.
Publicado: (2015)

Long-term treatment with cinacalcet and conventional therapy reduces parathyroid hyperplasia in severe secondary hyperparathyroidism
por: Meola, Mario, et al.
Publicado: (2009)

Association between long-term efficacy of cinacalcet and parathyroid gland volume in haemodialysis patients with secondary hyperparathyroidism
por: Tanaka, Motoko, et al.
Publicado: (2008)

The use of cinacalcet hinders the diagnosis of parathyroid carcinoma in a chronic dialysis patient: a case report
por: Takada, Daisuke, et al.
Publicado: (2017)

Cinacalcet is effective in the treatment of hyperparathyroidism secondary to malignant transformation of autotransplanted parathyroid tissue. A case report
por: Dattolo, Pietro, et al.
Publicado: (2010)

Failed Switching off in the MIBI-Parathyroid Scintigraphy in a Dialyzed Patient with Secondary Hyperparathyroidism Responsive to Cinacalcet Therapy
por: Bolasco, Piergiorgio, et al.
Publicado: (2010)

Cinacalcet: the chemical parathyroidectomy?
por: Bellasi, Antonio, et al.
Publicado: (2013)

Cinacalcet Treatment of Primary Hyperparathyroidism
por: Rothe, H. M., et al.
Publicado: (2011)

Vitamin D-Resistant Rickets and Cinacalcet—One More Favorable Experience
por: Nicolescu, Ramona C., et al.
Publicado: (2018)

Recurrent Metastasized Parathyroid Carcinoma—Long‐Term Remission After Combined Treatments With Surgery, Radiotherapy, Cinacalcet, Zoledronic Acid, and Temozolomide
por: Storvall, Sara, et al.
Publicado: (2018)

Cinacalcet in HIV haemodialysis patients
por: Belmouaz, Simohamed, et al.
Publicado: (2008)

Hypercalcemia of malignancy treated with cinacalcet
por: Asonitis, Nikolaos, et al.
Publicado: (2017)

Parathyroid hormone and parathyroid hormone type-1 receptor accelerate myocyte differentiation
por: Kimura, Shigemi, et al.
Publicado: (2014)

New insights into thyroid dysfunction in patients with inactivating parathyroid hormone/parathyroid hormone-related protein signalling disorder (the hormonal and ultrasound aspects): One-centre preliminary results
por: Januś, Dominika, et al.
Publicado: (2022)

Parathyroid hormone 1-34 and skeletal anabolic action: The use of parathyroid hormone in bone formation
por: Osagie-Clouard, L., et al.
Publicado: (2017)

Utility of Cinacalcet in Familial Hypocalciuric Hypercalcemia
por: Sethi, Bipin Kumar, et al.
Publicado: (2017)

Clinical Use of Cinacalcet in MEN1 Hyperparathyroidism
por: Moyes, V. J., et al.
Publicado: (2010)

The Parathyroid Hormone-Related Protein/Parathyroid Hormone 1 Receptor Axis in Adipose Tissue
por: Izquierdo-Lahuerta, Adriana
Publicado: (2021)

Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis
por: Zhao, Yawei, et al.
Publicado: (2023)

Intermittent parathyroid hormone increases stability and improves osseointegration of initially unstable implants
por: Staats, Kevin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cs210i1q8a8ubnan73rh4dqb8d